PubMed
Society journal
Impact Factor 8.5

European Association of Urology

EAU on MedicMess

European Urology Oncology

Indexed in MEDLINE (PubMed). Published by Elsevier BV for the European Association of Urology.

European Urology Oncology publishes research on cancers of the urinary and reproductive systems. Its scope brings together urology, medical oncology, radiotherapy, imaging, pathology and basic research, including clinical and translational studies.
Reviewed byDr Robert BaxterDr Robert Baxter· Junior Clinical Fellow, Acute Medical Unit· Updated 17 Oct 2026

Publishing in European Urology Oncology

European Urology Oncology is an official journal of the European Association of Urology, published by Elsevier. It focuses on genitourinary cancers across urology, medical oncology, radiotherapy, imaging, pathology and basic research. The guide lists original research, systematic reviews, rapid reviews, clinical trial protocols and updates, brief reports, research letters, invited editorials and short clinical innovation pieces. Reviews are normally solicited by the editors.

Authors can publish through the subscription route without an open access fee. Optional open access costs US$4,190 before tax, although an institutional agreement or the author's circumstances may change the charge. The journal reports a 2025 Impact Factor of 8.5 and 24 days from submission to a decision after review. External experts review manuscripts selected by the editors, and reviewers see author identities. The guide mentions case reports in its disclosure rules but gives no dedicated submission instructions.

Free subscriber access

Free with a subscription: the author guide in one place

Word limits, abstract lengths and fees for each article type, and a checklist before you submit. Enter your email to unlock this journal and every other guide.

  • Original Articles

    Original clinical, basic or translational research in urologic oncology.

    Words
    2,750
    Abstract
    250
    Figures & tables
    6
    References
    40
    Structured abstract
  • Review Articles

    Usually invited systematic reviews and meta analyses of diagnosis, treatment or prognosis.

    Words
    3,750
    Abstract
    250
    Figures & tables
    6
    References
    60
    Structured abstractFollow PRISMA
  • Rapid Reviews

    Brief reviews of a new topic with a patient summary.

    Words
    1,150
    Abstract
    150
    Figures & tables
    2
    References
    10
    Unstructured abstract
  • Clinical Trial Protocol

    Registered phase two or three urologic oncology trial protocols and updates.

    Words
    2,750
    Abstract
    250
    Figures & tables
    6
    References
    30
    Structured abstract
  • Clinical Trial Update

    Results updates from registered urologic oncology clinical trials.

    Words
    2,750
    Abstract
    250
    Figures & tables
    6
    References
    30
    Structured abstract
  • EUO Priority Editorial

    Invited commentary on a current topic or a paper in the issue.

    Words
    1,000
    Abstract
    —
    Figures & tables
    1
    References
    10
  • Letters to the Editor about a recent journal article

    Comments on a recent article submitted within three months of publication.

    Words
    500
    Abstract
    —
    Figures & tables
    0
    References
    5
  • Research Letters

    Original findings suited to a shorter letter format.

    Words
    500
    Abstract
    —
    Figures & tables
    1
    References
    5
  • Brief Report

    Concise original research with a patient summary.

    Words
    1,000
    Abstract
    200
    Figures & tables
    2
    References
    10
    Unstructured abstract
  • New Frontiers in Oncology

    Brief clinical innovations that connect research with patient care.

    Words
    750
    Abstract
    250
    Figures & tables
    2
    References
    10
    Unstructured abstract

The subscription publication route has no open access fee. Optional open access costs US$4,190 before tax for all article types. Institutional agreements and personal circumstances may change the open access charge.

Before you submit

  • Submit the required authorship and financial disclosure form with original and review articles.
  • Register interventional clinical trials before patient enrolment and include the registry details in the abstract.
  • Use PRISMA for systematic reviews and include the required patient summary.
  • Upload a separate take home message with original articles, reviews and rapid reviews.
  • Disclose related publications and any earlier preprint when submitting.
  • For subscription articles, wait 12 months after publication to share the accepted manuscript publicly.

Present it first.

Similar journals.

Frequently asked

Is European Urology Oncology indexed in PubMed?
Yes. European Urology Oncology is indexed in MEDLINE, so its articles are in PubMed with a PMID.
How much does it cost to publish in European Urology Oncology?
There is a free route: authors can publish without a fee.
Does European Urology Oncology accept case reports?
No. European Urology Oncology does not publish case reports.
What is the Impact Factor of European Urology Oncology?
European Urology Oncology states an Impact Factor of 8.5 for 2025.
How long does European Urology Oncology take to decide?
About 24 days from submission to first decision.

MEDLINE · Free route · First decision in 24 days

Accepted work
Original research · Systematic review · Clinical trial
Acceptance rate
Not stated
Peer review
Not stated
Access
Subscription or individual open access article · Subscribe ↗
Author guide

Checked against the journal’s author guide · updated 17 Oct 2026